Form 8-K - Current report:
SEC Accession No. 0001213900-25-033295
Filing Date
2025-04-18
Accepted
2025-04-18 14:30:54
Documents
13
Period of Report
2025-04-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0238654-8k_oncon.htm   iXBRL 8-K 27063
  Complete submission text file 0001213900-25-033295.txt   203321

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20250414.xsd EX-101.SCH 3041
3 XBRL LABEL FILE onco-20250414_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE onco-20250414_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0238654-8k_oncon_htm.xml XML 3795
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 25850152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)